‘The Better Half: On the Genetic Superiority of Women’

From birth, genetic females are better at fighting viruses, infections and cancer. They do better at surviving epidemics and famines. They live longer, and even see the world in a wider variety of colours. These are the facts; they are simply stronger than men at every stage of life. Why? And why are we taught the opposite?

Drawing on his wide-ranging experience and cutting-edge research as a medic, geneticist and specialist in rare diseases, Dr Sharon Moalem set out to understand why women are consistently more likely than men to thrive. The answer, he reveals, lies in our genetics: the female's double XX chromosomes offer a powerful survival advantage.

Moalem explains why genetic females outperform males when it comes to immunity, resilience, stamina and much more. And he calls for a long-overdue reconsideration of our male-centric, one-size-fits-all view of the body and of how we prescribe medications - a view that still frames women through the lens of men. Revolutionary, captivating and utterly persuasive, The Better Half will make you see women, men and the survival of our species anew.

The Better Half: On the Genetic Superiority of Women
by Sharon Moalem (Author)
Published in Hardcover (7 April 2020)
Publisher: Allen Lane (7 April 2020)
Language: English, 288 pages
ASIN: B07YBQWB69 (Kindle)
ISBN-10: 0241396883 (Hardcover)
ISBN-10: 1250782732 (Paperback)
Guide Price: £9.99 - Kindle | £20 - Hardcover | £13.83 - Paperback
Click to buy Kindle Edition | Hardcover | Paperback

About the Author

Sharon Moalem, MD, PhD, is an award-winning genetics researcher, physician and bestselling author. He is the author of the New York Times bestseller Survival of the Sickest and Inheritance, an Amazon Best Science Book of the Year, among other books. His work brings together evolution, genetics, and medicine to revolutionize how we understand and treat disease, and his clinical research led to the discovery of two new rare genetic conditions, and to his discovery of a first-in-class antibiotic which targets 'superbug' infections. His books have been translated into more than 35 languages.